Literature DB >> 1649222

Modulation of cytolytic T lymphocyte functions by an inhibitor of serine/threonine phosphatase, okadaic acid. Enhancement of cytolytic T lymphocyte-mediated cytotoxicity.

R E Taffs1, F A Redegeld, M V Sitkovsky.   

Abstract

A specific and potent inhibitor of protein phosphatases 1 and 2A, okadaic acid (OA), and its inactive analog, tetramethyl ether (OA-TME), were tested in the cytotoxicity and granule exocytosis assays of CTL activation. At low concentrations OA enhanced, whereas at higher concentrations OA inhibited, CTL responses. The Ag-specific and retargeted cytotoxicity, granule exocytosis induced by target cell (TC), anti-TCR mAb, or PMA and A23187, and conjugate formation with TC were inhibited by pretreatment of CTL with OA as expected if protein phosphatases and protein dephosphorylation were indeed involved in the TCR-mediated signal transduction and effector responses of CTL. Cytotoxicity and granule exocytosis were unaffected by pretreatment of CTL with OA-TME. The inhibitory effect of OA on the exocytic response of CTL induced by TC and anti-TCR mAb can be dissociated from the inhibition of the response to PMA and A23187, suggesting the involvement of a serine and/or threonine protein phosphatase in the early events of transmembrane signaling. At lower concentrations, OA, but not OA-TME, was able to enhance the Ag-specific cytotoxicity and TC-induced exocytosis from CTL clones. The enhancement of these TCR-mediated responses of CTL was observed only if the activation was induced by the Ag on the TC surface, because OA did not enhance either the anti-TCR mAb-induced exocytosis of granules from the CTL clone or lysis of the Ag-nonbearing TC by CTL in a retargeting assay. The biphasic character of the effects of OA on CTL-TC interactions suggests the existence of at least two functionally distinct phosphatases in CTL. The ability of OA to enhance the Ag-specific response is unique and indicates the presence of an inhibitory phosphoprotein phosphatase that should be considered as a participant in the down-regulation of the cell-cell interactions between CTL and TC. The inhibitory effects of OA on both TC-induced and anti-TCR mAb-triggered CTL responses at higher concentrations point to the importance of yet another phosphatase in the CTL-TC interactions and in the TCR-mediated transmembrane signaling. The use of OA may help to decipher the details of biochemical changes involved in T lymphocyte effector functions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649222

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Inhibition of protein phosphatase-2A with LB-100 enhances antitumor immunity against glioblastoma.

Authors:  Dominic Maggio; Winson S Ho; Rebecca Breese; Stuart Walbridge; Herui Wang; Jing Cui; John D Heiss; Mark R Gilbert; John S Kovach; Rongze O Lu; Zhengping Zhuang
Journal:  J Neurooncol       Date:  2020-04-27       Impact factor: 4.130

2.  Regulation of human basophil function by phosphatase inhibitors.

Authors:  M J Peirce; J A Warner; M R Munday; P T Peachell
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

3.  Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase enzyme activity in human T-cells.

Authors:  Anne Denys; Aziz Hichami; Naim Akhtar Khan
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

4.  Contrasting effects of two tumour promoters, phorbol myristate acetate and okadaic acid, on T-cell responses and activation of p42 MAP-kinase/ERK-2.

Authors:  M C Amaral; A M Casillas; A E Nel
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

5.  Pharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade.

Authors:  Winson S Ho; Herui Wang; Dominic Maggio; John S Kovach; Qi Zhang; Qi Song; Francesco M Marincola; John D Heiss; Mark R Gilbert; Rongze Lu; Zhengping Zhuang
Journal:  Nat Commun       Date:  2018-05-29       Impact factor: 14.919

6.  Protein phosphatase 2A inactivation induces microsatellite instability, neoantigen production and immune response.

Authors:  Yu-Ting Yen; May Chien; Pei-Yi Wu; Chi-Chang Ho; Chun-Te Ho; Kevin Chih-Yang Huang; Shu-Fen Chiang; K S Clifford Chao; William Tzu-Liang Chen; Shih-Chieh Hung
Journal:  Nat Commun       Date:  2021-12-15       Impact factor: 17.694

7.  Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death.

Authors:  Enyu Rao; Yuwen Zhang; Ganqian Zhu; Jiaqing Hao; Xuan-Mai T Persson; Nejat K Egilmez; Jill Suttles; Bing Li
Journal:  Oncotarget       Date:  2015-04-10

8.  Ionic immune suppression within the tumour microenvironment limits T cell effector function.

Authors:  Robert Eil; Suman K Vodnala; David Clever; Christopher A Klebanoff; Madhusudhanan Sukumar; Jenny H Pan; Douglas C Palmer; Alena Gros; Tori N Yamamoto; Shashank J Patel; Geoffrey C Guittard; Zhiya Yu; Valentina Carbonaro; Klaus Okkenhaug; David S Schrump; W Marston Linehan; Rahul Roychoudhuri; Nicholas P Restifo
Journal:  Nature       Date:  2016-09-14       Impact factor: 49.962

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.